Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial

被引:0
|
作者
Foa, A. Alberto [1 ]
Claggett, B. L. [1 ]
Miao, M. [1 ]
Pabon, M. [1 ]
Lu, H. [1 ]
Pfeffer, M. A. [1 ]
Packer, M. [2 ]
Rouleau, J. L. [3 ]
Lefkowitz, M. [4 ]
Desai, A. S. [1 ]
Mcmurray, J. J. V. [5 ]
Solomon, S. D. [1 ]
Vaduganathan, M. [1 ]
机构
[1] Harvard Med Sch, Brigham & WomenS Hosp, Boston, MA 02115 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[3] Univ Montreal, Cardiol, Montreal, PQ, Canada
[4] Novartis, E Hanover, NJ USA
[5] BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:225 / 226
页数:2
相关论文
共 46 条
  • [21] Efficacy and safety of sacubitril/valsartan according to frailty in heart failure with preserved ejection fraction: a post hoc analysis of the PARAGON-HF trial
    Butt, J. H.
    Dewan, P.
    Kober, L.
    Jhund, P. S.
    Solomon, S. D.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1052 - 1052
  • [22] DECLINE IN ESTIMATED GLOMERULAR FILTRATION RATE FOLLOWING SACUBITRIL/VALSARTAN INITIATION IN PATIENTS WITH HEART FAILURE: INSIGHTS FROM PARAGON-HF AND PARADIGM-HF
    Chatur, Safia
    Vaduganathan, Muthiah
    Claggett, Brian
    Mc Causland, Finnian
    Rouleau, Jean L.
    Zile, Michael R.
    Packer, Milton
    Pfeffer, Marc A.
    Lefkowitz, Martin
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 276 - 276
  • [23] Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials
    Kondo, T.
    Jhund, P. S.
    Anand, I. S.
    Desai, A. S.
    Lam, C. S. P.
    Maggioni, A. P.
    Martinez, F. A.
    Redfield, M. M.
    Rouleau, J. L.
    Van Veldhuisen, D. J.
    Zannad, F.
    Zile, M. R.
    Packer, M.
    Solomon, S. D.
    Mcmurray, J. J., V
    EUROPEAN HEART JOURNAL, 2024, 45
  • [24] Letter by Tuncez and Gurses Regarding Article, "Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF"
    Tuncez, Abdullah
    Gurses, Kadri Murat
    CIRCULATION, 2025, 151 (06) : e37 - e37
  • [25] Response by Shen et al to Letter Regarding Article, "Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF"
    Shen, Li
    Jhund, Pardeep S.
    Mcmurray, John J. V.
    CIRCULATION, 2025, 151 (06) : e38 - e38
  • [26] Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m2: Insights From PARAGON-HF and PARADIGMHF
    Chatur, Safia
    Vaduganathan, Muthiah
    Claggett, Brian L.
    McCausland, Finnian
    Desai, Akshay S.
    Beldhuis, Iris
    Rouleau, Jean L.
    Zile, Michael R.
    Packer, Milton
    Pfeffer, Marc A.
    Lefkowitz, Martin P.
    McMurray, John J.
    Solomon, Scott D.
    CIRCULATION, 2023, 148
  • [27] IN-HOSPITAL OR OUT-OF-HOSPITAL INITIATION OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN IN PATIENTS WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION AFTER A WORSENING HEART FAILURE EVENT: THE PARAGLIDE-HF TRIAL
    Nouhravesh, Nina
    Erickson, Tyler
    Cyr, Derek D.
    Hernandez, Adrian F.
    Morrow, David A.
    Velazquez, Eric J.
    Ward, Jonathan
    Williamson, Kristin
    Starling, Randall C.
    Zieroth, Shelley R.
    Solomon, Scott D.
    Braunwald, Eugene
    Mentz, Robert John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 377 - 377
  • [28] In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial
    Nouhravesh, Nina
    Cyr, Derek
    Hernandez, Adrian F.
    Morrow, David A.
    Velazquez, Eric J.
    Ward, Jonathan
    Sarwat, Samiha
    Sharma, Kavita
    Williamson, Kristin
    Starling, Randall C.
    Lepage, Serge
    Zieroth, Shelley
    Solomon, Scott D.
    Mentz, Robert J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (05):
  • [29] Evaluation of event-free survival as a trial-level surrogate for overall survival for patients with gastric and gastroesophageal junction adenocarcinoma in neoadjuvant/adjuvant settings
    Xie, J.
    Valderrama, A.
    Yin, L.
    Zhang, S.
    Shih, C-S.
    Gu, C.
    Bhagia, P.
    Wainberg, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S1052 - S1053
  • [30] Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial
    Heesen, Philip
    Ranft, Andreas
    Bhadri, Vivek
    Brichard, Benedicte
    Collaud, Stephane
    Cyprova, Sona
    Eich, Hans
    Ek, Torben
    Gelderblom, Hans
    Hardes, Jendrik
    Haveman, Lianne
    Jabar, Susanne
    Hartmann, Wolfgang
    Andreou, Dimosthenis
    Hauser, Peter
    Kersting, Josephine
    Juergens, Heribert
    Kanerva, Jukka
    Kuehne, Thomas
    Raciborska, Anna
    Rascon, Jelena
    Streitbuerger, Arne
    Timmermann, Beate
    Uhlenbruch, Yasmin
    Dirksen, Uta
    EUROPEAN JOURNAL OF CANCER, 2023, 192